Press Releases August 5, 2026 09:34 AM

Stryker declares an $0.88 per share quarterly dividend

Stryker announces a 4.8% increase in quarterly dividend to $0.88 per share

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation declared a quarterly dividend of $0.88 per share, payable on July 31, 2026, to shareholders of record as of June 30, 2026. This represents a 4.8% increase compared to the prior year dividend rate and remains unchanged from the previous quarter. Stryker is a global leader in medical technologies, focusing on MedSurg, Neurotechnology, and Orthopaedics sectors, impacting over 150 million patients annually.

Stryker declares an $0.88 per share quarterly dividend
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker increased its quarterly dividend by 4.8% compared to last year, signaling confidence in its financial health.
  • The dividend remains stable compared to the previous quarter, suggesting steady cash flow.
  • Stryker operates in the medical technologies sector with a broad impact on patient healthcare outcomes globally.

Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. 

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or [email protected]   

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or [email protected]


Risks

  • Dividend increases depend on continued strong financial performance, which could be affected by market conditions or operational risks.
  • Medical technology sector faces regulatory and innovation risks that could impact future profitability.
  • Global economic or healthcare funding changes may influence Stryker's revenue streams and dividend sustainability.

More from Press Releases

Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026 Jasper Therapeutics Announces 1-for-30 Reverse Stock Split Nov 4, 2026